Inferior Survival in Double Refractory Large B-Cell Lymphoma Eligible for Third-Line CD19 Chimeric Antigen T-Cell Therapy
Carmel Waldron, Richard Tsang, David Hodgson, Danielle Rodin et al.
Journal
Blood
Topics
CAR-T cell therapy research
article
Inferior Survival in Double Refractory Large B-Cell Lymphoma Eligible for Third-Line CD19 Chimeric Antigen T-Cell Therapy
Carmel Waldron, Richard Tsang, David Hodgson, Danielle Rodin, Anca Prica, Chathuri Abeyakoon, Robert Kridel, Katrina Hueniken, Nauman Malik, Michael Crump, Vishal Kukreti, Christine I. Chen, Sita Bhella, Rachel Aitken, Abi Vijenthira, John Kuruvilla, Woodrow Wells, Jing Yang
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 144(Supplement 1)
Institutions
University Health Network (CA), Princess Margaret Cancer Centre (CA), St. James's Hospital (IE)